Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2301570rdf:typepubmed:Citationlld:pubmed
pubmed-article:2301570lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2301570lifeskim:mentionsumls-concept:C0027740lld:lifeskim
pubmed-article:2301570lifeskim:mentionsumls-concept:C0034791lld:lifeskim
pubmed-article:2301570lifeskim:mentionsumls-concept:C0013470lld:lifeskim
pubmed-article:2301570lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:2301570pubmed:issue1 Pt 1lld:pubmed
pubmed-article:2301570pubmed:dateCreated1990-3-1lld:pubmed
pubmed-article:2301570pubmed:abstractTextThis study was designed to determine the specificity and physiological nature of short-term satiety effects of cholecystokinin (CCK) in rats with intact and transected vagal nerves. Rats with-the gastric fistulas, closed or open, were used for normal feeding or sham feeding of liquid meal offered for 30 min. CCK-8 (0.5-10 nmol/kg) injected intraperitoneally (ip) 15 min before feeding inhibited food intake dose dependently in both normal-fed and sham-fed rats at a minimal inhibitory dose of 1 nmol/kg. CCK-8 at the same doses caused a potent stimulation of pancreatic protein secretion, reaching maximum at a dose of approximately 0.5 nmol/kg. Pretreatment with a potent CCK receptor antagonist, L-364,718 (2.5 mg/kg ip), increased food intake during normal feeding (but not sham feeding) and almost completely blocked the satiety and pancreatic stimulatory effects of CCK. When feeding was preceded by intragastric administration of proteinase inhibitor (Foy-305, 200 mg/kg), food preload, or diversion of bile-pancreatic secretion to the exterior, there was a significant increase in the plasma level of CCK and an inhibition of food intake by about 36, 78, and 25%, respectively. Pretreatment with L-364,718 completely abolished this inhibition by Foy-305 and bile-pancreatic diversion and reduced that caused by food preload. Among other gut peptides given ip (10 nmol/kg) only bombesin reduced food intake, whereas gastrin, secretin, gastric inhibitory polypeptide (GIP), pancreatic polypeptide (PP), and peptide YY (PYY) were ineffective.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2301570pubmed:languageenglld:pubmed
pubmed-article:2301570pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2301570pubmed:citationSubsetIMlld:pubmed
pubmed-article:2301570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2301570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2301570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2301570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2301570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2301570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2301570pubmed:statusMEDLINElld:pubmed
pubmed-article:2301570pubmed:monthJanlld:pubmed
pubmed-article:2301570pubmed:issn0002-9513lld:pubmed
pubmed-article:2301570pubmed:authorpubmed-author:KonturekS JSJlld:pubmed
pubmed-article:2301570pubmed:authorpubmed-author:KwiecienNNlld:pubmed
pubmed-article:2301570pubmed:authorpubmed-author:GarlickiJJlld:pubmed
pubmed-article:2301570pubmed:authorpubmed-author:MajkaJJlld:pubmed
pubmed-article:2301570pubmed:authorpubmed-author:KonturekP KPKlld:pubmed
pubmed-article:2301570pubmed:issnTypePrintlld:pubmed
pubmed-article:2301570pubmed:volume258lld:pubmed
pubmed-article:2301570pubmed:ownerNLMlld:pubmed
pubmed-article:2301570pubmed:authorsCompleteYlld:pubmed
pubmed-article:2301570pubmed:paginationE40-5lld:pubmed
pubmed-article:2301570pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:meshHeadingpubmed-meshheading:2301570-...lld:pubmed
pubmed-article:2301570pubmed:year1990lld:pubmed
pubmed-article:2301570pubmed:articleTitleCholecystokinin receptors and vagal nerves in control of food intake in rats.lld:pubmed
pubmed-article:2301570pubmed:affiliationInstitute of Physiology, Academy of Medicine, Krakow, Poland.lld:pubmed
pubmed-article:2301570pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2301570pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2301570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2301570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2301570lld:pubmed